This is dead money until at least the first quarter of next year. There is no news coming. I'll ask again -- what do you think the low will be between now and the fda decision next year. Low 9's? Low 8's.
ACRX have been one of the best performing stocks thus far this year in my portfolio... the success of ACRX will continue and bigger than others like PCRX in due time.. buy and hold this stock. Dom Times ahead for ACRX
Sentiment: Strong Buy
WHY BUY THIS STOCK NOW? Because you like to make money. I started buying ACRX in the low $6.00's and have consistently added since then. I can tell you many reasons that the share price will increase, but you're not interested in that, are you?
This is the best board I have found... Bar None.
I am interested in the company --- don't own any shares --- am not short -- want to own shares -- but the investor in me says that with no news i can get a lower price. Why buy a 100000 bucks of at stock at 10.75 when you can buy it in the 9's or the 8's. just trying to get the boards idea of what they think the lower price will be.
everyone always assumes that questions are a short indicator.
Move along ... nothing to see here!
I find it so amusing when folks like yourself post rhetorical questions, when you can simply choose to move on to another stock/board with so much more promise! Things that make you go .... hmmmmmmmmmm?
Because they are going to sign an EU partnership by the end of the year, unless a buyout comes first. This should be a major deal, and will jump the price significantly. This is only dead money until it isn't, and then you've missed a big run-up.
rxkell - Admittedly I am not a professional trader, but then, neither are you. I could take the unsolicited advice of an unknown blogger who has an obvious agenda, or I could take a look at the consensus of brokerages. It's a tough decision.... follow a shorter, or five major brokerages who have boosted ACRX's share price target within the past four months and have a concensus price target of $14.19. Sorry, I think I'll go with the real analysts.
Cannacord Genuity Boosted Price Target 8/13/2013 $13.00
Jefferies Group Boosted Price Target 8/13/2013 $14.00
Mizuho Boosted Price Target 7/17/2013 $18.00
Guggenheim Boosted Price Target 5/28/2013 $15.00
JMP Securities Boosted Price Target 5/3/2013 $12.00